AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.22), $0.11 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $9.09 million versus the consensus estimate of $7.47 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.